Elizabeth María De Freitas-González

Mrs. Elizabeth María De Freitas-González


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
MRMiriam Retuerto
Miriam Retuerto
RLRamiro López-Medrano
Ramiro López-Medrano
EFElizabeth María De Freitas-González
Elizabeth María De Freitas-González
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
Nontuberculous mycobacteria (NTM) are environmental and ubiquitous, but only a few species are associated with disease, often presented as nodular/bronchiectatic or cavitary pulmonary forms. Bronchiectasis, airways dilatations characterized by chronic productive cough, is the main presentation of NTM pulmonary disease. The current Cole’s vicious circle model for bronchiectasis proposes that it progresses from a damaging insult, such as pneumonia, that affects the respiratory epithelium and compromises mucociliary clearance mechanisms, allowing microorganisms to colonize the airways. An important bronchiectasis risk factor is primary ciliary dyskinesia, but other ciliopathies, such as those associated with connective tissue diseases, also seem to facilitate bronchiectasis, as may occur in Lady Windermere syndrome, caused by M. avium infection. Inhaled NTM may become part of the lung microbiome. If the dose is too large, they may grow excessively as a biofilm and lead to disease. The incidence of NTM pulmonary disease has increased in the last two decades, which may have influenced the parallel increase in bronchiectasis incidence. We propose that ciliary dyskinesia is the main promoter of bronchiectasis, and that the bacteria most frequently involved are NTM. Restoration of ciliary function and impairment of mycobacterial biofilm formation may provide effective therapeutic alternatives to antibiotics.

30 March 2026 in Biology
Verified
Journal Article
Open access
PDF file
RLRamiro López-Medrano
Ramiro López-Medrano
MRMiriam Retuerto
Miriam Retuerto
EFElizabeth María De Freitas-González
Elizabeth María De Freitas-González
CTCristina - Diez Tascón
Cristina - Diez Tascón
CPCarmen del Mar Pérez-López
Carmen del Mar Pérez-López
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
Mycobacteria isolated only once in repeated sputum cultures are deemed colonizers that are not normally present in the lungs despite their ubiquitous presence in the environment. We have developed a sensitive and specific PCR assay to detect slow-growing mycobacteria in culture negative sputum and have found them in 30% of the samples obtained from individuals with clinical suspicion of tuberculosis or mycobacteriosis (n = 50) and in 45% of the samples from individuals with no suspicion (n = 49). As a negative control we have analyzed infections from an extra-pulmonary location, the urinary tract (n = 21), in which mycobacterioses are rare, and did not detect them. The load of bacteria in the lungs is kept low by the defense mechanisms of the host, and mycobacteria are not normally detected in sputum cultures. Their incidental isolation would not be a consequence of a new exposure to the microorganism but a sign of susceptibility to mycobacteriosis.

Verified
Journal Article
Open access
PDF file
SBSara Luisa Blanco-Conde
Sara Luisa Blanco-Conde
MRMiriam Retuerto
Miriam Retuerto
RLRamiro López-Medrano
Ramiro López-Medrano
CCCristina López Cadenas
Cristina López Cadenas
SVSantiago Vivas-Alegre
Santiago Vivas-Alegre
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
Immunosuppressive therapies increase the risk of infection, but there is little information regarding their effects on cellular antimycobacterial activity. In this context, the aim was to evaluate in vitro the impact of commonly used immunosuppressive drugs on the ability of peripheral blood mononuclear cells (PBMCs), neutrophils (polymorphonuclear cells, PMNs), and monocyte-derived macrophages (MDMs) to control Mycobacterium abscessus. Biofilm formation was assessed by quantifying bacterial colonies in cellular cultures (BCCCs) and bacterial viability by colony-forming units (CFUs). BCCCs showed significant differences among treatment conditions in PBMCs. The median (interquartile range) BCCC values for tacrolimus (TAC) 16.5 (41), everolimus (EVE) 11 (33), methotrexate (MTX) 12.5 (22) and leflunomide (LEF) 11 (29) were all significantly higher than the negative control (DMSO) 5 (14), indicating that these immunosuppressants impaired the ability of PBMCs to restrict BCCC formation. Log-transformed CFUs also varied across treatments in PMNs. Mycophenolic acid (MPA) 5.98 (2.61) and EVE 5.85 (2.77) increased LogCFU recovery compared with DMSO 5.58 (2.63), whereas MTX 5.18 (2.74) decreased it. In contrast, immunosuppressants had no significant overall effect in MDM cultures. Interestingly, 6-mercaptopurine (6MP) affected the size of colonies. Prednisolone, as expected, but also MTX and LEF, inhibited the expression in infected PBMCs of IL-1β, IL-1Ra, IL-6, CCL3, CCL5, CXCL8 and TIMP-2, whereas IL-10, CCL2 and CXCL7 expression remained essentially unchanged. Unexpectedly, methotrexate promoted CXCL8 expression, a chemokine for PMNs. These results show that commonly used immunosuppressive drugs can differentially modulate the antimycobacterial activity of PBMCs and innate immune cells, affecting both mycobacterial viability and biofilm formation.